Cat. No. 0455
Chemical Name: (S)-α-Hydrazino-α-methyl-β-(3,4-dihydr
Biological ActivityPeripheral decarboxylase inhibitor, used in combination with levodopa for treatment of Parkinsonism.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Cheng et al (1992) Carbidopa inhibition of aromatic L-amino acid decarboxylase in rat brain capilliaries. FASEB J. 6 A1589.
Kopfhammer et al (1985) L-Dopa infusion experiments in combination with the L-dopa decarboxylase inhibitors benserazide and carbidopa - L-dopa metabolism and neuroendocrinological effects. Pharmacopsychiatry 18 143.
Merck Index 12 1843.
If you know of a relevant reference for (S)-(-)-Carbidopa please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses (S)-(-)-Carbidopa from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: (S)-(-)-Carbidopa, supplier, Aromatic, Lamino, acid, decarboxylase, inhibitors, inhibits, Tocris Bioscience, Decarboxylase Inhibitor products
Find multiple products by catalog number
New Products in this Area
Fluorometric CYP450 substrateGaleterone
CYP17 inhibitor; also androgen receptor antagonistPF 04449613
Potent PDE9 inhibitor; brain penetrant
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.